Placeholder Banner

BIO Statement on CMS' Approval of TennCare Medicaid Waiver

January 11, 2021
Media Contact
Vicky Stinson

Dan Durham, Executive Vice President for Health Policy at the Biotechnology Innovation Organization, released the following statement regarding the recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve the Tennessee Medicaid (TennCare) Section 1115 waiver demonstration:

"We are extremely disappointed that CMS has chosen to approve a waiver demonstration that will put Tennessee Medicaid (TennCare) patients at risk. This dangerous decision will jeopardize access to critical medicines for some of our most vulnerable patients. BIO believes CMS does not have the legal authority to approve the waiver and closed formulary and we will work to protect patient access to the life-saving medicines they need.”

Discover More
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the White House's support of waiving critical intellectual property rights for COVID-19…
Today, Congress passed the “American Rescue Plan” – a $1.9 trillion coronavirus relief package aimed at alleviating some of the economic and health impacts of the COVID-19 pandemic. Upon passage of the bill, Dr. Michelle McMurry-Heath, president…
BIO to assess successes and challenges at its Digital Convention in June